FDA Approved: PULMOZYME — Supplemental Application (Genentech, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Pulmozyme (dornase alfa) from Genentech, Inc., under the original Biologics License Application.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Pulmozyme (dornase alfa)

Snippet

SUPPL AP for PULMOZYME (DORNASE ALFA)